Intra-Cellular Therapies Inc. Watch

from 10-Q 10 pages Intra-Cellular Therapies, Inc. [Amended and Restated] Employee Proprietary Information, Inventions, and Non-Competition Agreement

from 10-Q 5 pages Schedule B Release of Claims

from 8-K 7 pages Intra-Cellular Therapies, Inc. Consulting Agreement

from 8-K 6 pages Lawrence J. Hineline Re: Transition From Employee to Consultant in Connection With Your Retirement Dear Larry,

from 8-K 8 pages Intra-Cellular Therapies, Inc. Employee Proprietary Information, Inventions, and Non-Competition Agreement

from 8-K 15 pages Employment Agreement

from 8-K 3 pages August 2, 2024 Sanjeev Narula [***] [***] Re: Offer Letter Dear Sanjeev: Iti, Inc. (The “Company”), a Wholly Owned Subsidiary of Intra-Cellular Therapies, Inc., Is Pleased to Offer You the Full-Time Position of Executive Vice President, Chief Financial Officer. the Terms of the Company’s Employment Offer Are as Follows: Your Start Date Will Be August 12, 2024. You Will Report to Sharon Mates, CEO. the Company May Change Your Position, Duties, and Work Location as It Deems Necessary. as a Salaried Employee, Your Compensation Will Be $25,625.00 Per Semi-Monthly Pay Period, Less Payroll Deductions and Other Withholdings Required by Law. This Semi-Monthly Compensation Is Equivalent to $615,000.00 Over the Course of One Year

from 8-K 16 pages Intra-Cellular Therapies, Inc. Amended and Restated 2018 Equity Incentive Plan Adopted by the Board of Directors: April 25, 2018 Approved by the Stockholders: June 18, 2018 Amended and Restated by the Board of Directors: April 6, 2020 Approved by the Stockholders: May 27, 2020 Amended and Restated by the Board of Directors: April 22, 2024 Approved by the Stockholders: June 14, 2024 Effective Date: June 18, 2018

from 10-Q 10 pages Intra-Cellular Therapies, Inc. Amended and Restated 2018 Equity Incentive Plan Performance-Based Restricted Stock Unit Award Grant Notice

from 10-Q 4 pages Intra-Cellular Therapies, Inc. Non-Employee Director Compensation Policy

from 10-K 3 pages Intra-Cellular Therapies, Inc. Clawback Policy

from 10-Q ~5 pages Intra-Cellular Therapies, Inc. Non-Employee Director Compensation Policy

from 10-K 6 pages Certain Information Identified by “[***]” Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. Amendment No. 1 to the Master Services Agreement Dated 10 January 2017 Between Lonza Ltd and Iti Limited

from 10-K 32 pages Certain Information Identified by “[***]” Has Been Excluded From the Exhibit Because It Is Both Not Material and Is the Type of Information That the Registrant Treats as Private or Confidential. January 5, 2023 Supply Agreement

from 8-K 70 pages License Agreement Between Intra-Cellular Therapies, Inc. and Bristol-Myers Squibb Company License Agreement

from 10-Q 3 pages Intra-Cellular Therapies, Inc. Non-Employee Director Compensation Policy

from 10-K 6 pages Intra-Cellular Therapies, Inc. Employee Proprietary Information, Inventions, and Non-Competition Agreement

from 10-K 13 pages Employment Agreement

from 8-K 29 pages Supply Agreement

from 8-K 2 pages Amendment